OR WAIT null SECS
November 15, 2013
Covance Inc. and Pathoquest have announced a collaboration to provide next-generation sequencing (NGS) based biosafety assessments to detect and identify viral contaminants within biologic compounds.
August 02, 2012
Meticulous system configuration can prevent machines from taking over.
May 02, 2012
Industry experts working with extended-release injectables discuss challenges and solutions to formulating and manufacturing these complex products.
November 10, 2011
On Sept. 27, 2011, FDA sent Genentech a Form 483 listing several violations at the company's South San Francisco, California, plant. The violations included problems with investigations into batch failures, inappropriate equipment design, and insufficient protection against contamination. FDA visited the plant, which produces the cancer drug Avastin, 13 times in September 2011 and made four observations.
September 01, 2011
Recently, there have been many innovations in the latest techniques and technologies in API purification. In particular, the trend to single-use systems has had a significant impact on processes.
January 19, 2011
A company's contamination-control plan is an important document designed to formalize the rationale, methods, and validation of contamination-control procedures in a manufacturing facility. The author describes the role of bioburden in the contamination-control plan.
January 02, 2009
The authors examine the challenges of integrating a large-scale chromatography and nanofiltration process for purification of a polyclonal antibody.
November 02, 2007
Editors' Picks of Pharmaceutical Science & Technology Innovations
October 01, 2007
High performance liquid chromatography has become an efficient technique at the production scale, and simulated moving bed chromatography provides several benefits during processing.
June 02, 2001
Special considerations and cautions must be adhered to when designing virus safety studies and developing appropriate virus contamination control programs.